| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/19/2002 | US20020131982 For use for preparing vaccines and immune stimulating compositions for oral, nasal, urogenital and/or rectal administration |
| 09/19/2002 | US20020131981 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
| 09/19/2002 | US20020131980 Comprises an immunizing amount of Mycoplasma hyopneumoniae bacterin, an adjuvant mixture comprising an acrylic acid polymer, a metabolizable oil, a polyoxyethylene polypropylene block copolymer, and an pharmaceutically acceptable carrier |
| 09/19/2002 | US20020131979 Reduces or prevents post-vaccination systemic reactions |
| 09/19/2002 | US20020131976 Tuberculosis vaccine |
| 09/19/2002 | US20020131975 Abundant extracellular products and methods for their production and use |
| 09/19/2002 | US20020131974 Administering a fusion protein of an antigen with an antigen presenting cell (APC) binding domain of an opsonin |
| 09/19/2002 | US20020131969 A beta-glucan and specific antibodies, such as antibodies specific to Staphylococcus Type 5 antigen or Type 8 antigen; IGIV (immune globulin intravenous) |
| 09/19/2002 | US20020131968 An Immunoglobulin G (IgG) antibody with binding affinity for the CD3 antigen in which the heavy chain has a variable region framework together with specified complementary determining region (CDR); immunosuppressant, treating cancer |
| 09/19/2002 | US20020131967 Such as melphalan and an anti-interleukin-6 receptor antibody, administering in synergistic amounts |
| 09/19/2002 | US20020131966 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 09/19/2002 | US20020131963 Methods and compositions for treating type i diabetes using glutamic acid decarboxylase |
| 09/19/2002 | US20020131960 Eukaryotic cell expressing beta 2-microglobulin and at least one exogenous accessory molecule; used to stimulate T cells of any patient of a given human leukocyte antigen (HLA) type |
| 09/19/2002 | US20020131953 In situ langerhans cell vaccine |
| 09/19/2002 | US20020131951 Biodegradable poly(beta-amino esters) and uses thereof |
| 09/19/2002 | DE10111433A1 Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen Replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from porcine and human cells |
| 09/19/2002 | CA2733610A1 Soluble heterodimeric cytokine receptor |
| 09/19/2002 | CA2702192A1 Igf antagonist peptides |
| 09/19/2002 | CA2479116A1 Targeted ligands |
| 09/19/2002 | CA2470152A1 Transfection complexes comprising a novel peptide as cell surface receptor binding component |
| 09/19/2002 | CA2454959A1 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2440974A1 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | CA2440658A1 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 09/19/2002 | CA2440345A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/19/2002 | CA2440131A1 Antibodies against human igg total fraction, and uses thereof in neutralising and treating hiv-1 |
| 09/19/2002 | CA2439953A1 Stabilized therapeutic and imaging agents |
| 09/19/2002 | CA2439735A1 Igf antagonist peptides |
| 09/19/2002 | CA2439612A1 Modulation of smooth muscle cell proliferation |
| 09/19/2002 | CA2439254A1 Life attenuated strains of prrs virus |
| 09/19/2002 | CA2439188A1 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | CA2438385A1 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 09/19/2002 | CA2437963A1 Therapeutic binding molecules |
| 09/19/2002 | CA2437958A1 Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors |
| 09/19/2002 | CA2434762A1 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | CA2433353A1 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | CA2408214A1 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents |
| 09/18/2002 | EP1241264A1 Monoclonal antibodies to colon cancer antigen |
| 09/18/2002 | EP1241259A1 Peptide having pronociceptive properties |
| 09/18/2002 | EP1241252A2 Human enteropeptidase-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241251A2 Human prostasin-like protein and nucleic acids encoding the same |
| 09/18/2002 | EP1241250A2 Human dehydrogenase-like protein and nucleic acid encoding it |
| 09/18/2002 | EP1241187A2 Fibilin-like polypeptide and nucleic acids encoding the same |
| 09/18/2002 | EP1241186A2 Human growth arrest specific gene 6 (gas-6) and nucleic acids encoding the same |
| 09/18/2002 | EP1241185A2 Human protocadherin-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241184A2 Human synaptogyrin-like protein and nucleic acids encoding the same |
| 09/18/2002 | EP1241183A2 HUman HCAR-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241180A2 Human A33 antigen-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241177A1 Recombinant infectious laryngotracheitis virus vaccine |
| 09/18/2002 | EP1240905A1 Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids |
| 09/18/2002 | EP1240526A2 Conformational and topological protein regulation |
| 09/18/2002 | EP1240521A2 Identification of disease markers involving mass-based-separation |
| 09/18/2002 | EP1240519A2 Compositions and methods for detecting treponema pallidum |
| 09/18/2002 | EP1240345A2 Methods for expression of genes in primates |
| 09/18/2002 | EP1240343A2 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 09/18/2002 | EP1240337A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 09/18/2002 | EP1240333A2 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 09/18/2002 | EP1240332A2 Streptococcus pyogenes virulence genes and proteins and their use |
| 09/18/2002 | EP1240331A2 i CHLAMYDIA /i ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 09/18/2002 | EP1240330A2 i PSEUDOMONAS AERUGINOSA /i ANTIGENS |
| 09/18/2002 | EP1240329A2 i STREPTOCOCCUS PNEUMONIAE /i ANTIGENS |
| 09/18/2002 | EP1240328A1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 09/18/2002 | EP1240327A2 Interferon-like molecules and uses thereof |
| 09/18/2002 | EP1240326A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/18/2002 | EP1240325A2 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 09/18/2002 | EP1240324A2 Polypeptides and nucleic acids encoding same |
| 09/18/2002 | EP1240317A2 Nucleic acid vaccination |
| 09/18/2002 | EP1240315A2 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof |
| 09/18/2002 | EP1240313A2 Homologues of human heparanase and splice variants thereof |
| 09/18/2002 | EP1240310A2 Method of inactivating microorganisms |
| 09/18/2002 | EP1240309A2 Immature autologous clinical grade dendritic cells intended for vaccination of cancer patients |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1240192A2 Attenuated microorganisms for the treatment of infection |
| 09/18/2002 | EP1240191A1 P. gingivalis antigenic composition |
| 09/18/2002 | EP1240189A2 Hepatitis virus sentinel virus i (svi) |
| 09/18/2002 | EP1240186A2 Improvements in or relating to immune responses to hiv |
| 09/18/2002 | EP1239876A1 Vaccine compositions |
| 09/18/2002 | EP1239875A1 Procedure to use staphylococcal bacteria |
| 09/18/2002 | EP1239874A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1239869A2 Tweak receptor |
| 09/18/2002 | EP1239866A1 INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| 09/18/2002 | EP1239734A1 Antioxidant compositions extracted from olives and olive by-products |
| 09/18/2002 | EP0943015B1 Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 09/18/2002 | EP0842267B1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
| 09/18/2002 | EP0789763B1 Icam-4 materials and methods |
| 09/18/2002 | EP0724432B1 Methods and compositions for microencapsulation of antigens for use as vaccines |
| 09/18/2002 | EP0693936B1 Cloned leptospira outer membrane protein |
| 09/18/2002 | EP0614486B1 Targeted delivery of virus vector to mammalian cells |
| 09/18/2002 | EP0592582B1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 09/18/2002 | CN1370237A Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of non-essential gene |
| 09/18/2002 | CN1370231A CASB618 polynucleotides and polypeptides and their use |
| 09/18/2002 | CN1370182A Compounds and methods for therapy and diagnosis of lung cancer |
| 09/18/2002 | CN1370083A Ninovasive genetic immnization, expression products therefrom, and uses thereof |
| 09/18/2002 | CN1370082A Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| 09/18/2002 | CN1370078A Prion protein peptides and uses thereof |
| 09/18/2002 | CN1370077A Vaccine against intra-cellular pathogens |
| 09/18/2002 | CN1370076A HM 1.24 antigen expression potentiators |
| 09/18/2002 | CN1369283A Eye drops containing bio-active catalytic enzyme |